| Improved long-term outcomes of patients with inflammatory bowel disease receiving proactive compared with reactive monitoring of serum concentrations of infliximab K Papamichael, KA Chachu, RK Vajravelu, BP Vaughn, J Ni, ... Clinical Gastroenterology and Hepatology 15 (10), 1580-1588. e3, 2017 | 223 | 2017 |
| Radioimmunotherapy of breast cancer metastases with α-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y H Song, RF Hobbs, R Vajravelu, DL Huso, C Esaias, C Apostolidis, ... Cancer research 69 (23), 8941-8948, 2009 | 169 | 2009 |
| Proactive infliximab monitoring following reactive testing is associated with better clinical outcomes than reactive testing alone in patients with inflammatory bowel disease K Papamichael, RK Vajravelu, BP Vaughn, MT Osterman, AS Cheifetz Journal of Crohn's and Colitis 12 (7), 804-810, 2018 | 116 | 2018 |
| In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver (I) complex, for treatment of pulmonary infections CL Cannon, LA Hogue, RK Vajravelu, GH Capps, A Ibricevic, KM Hindi, ... Antimicrobial agents and chemotherapy 53 (8), 3285-3293, 2009 | 89 | 2009 |
| Evaluation of Stethoscopes as Vectors of Clostridium difficile and Methicillin-Resistant Staphylococcus aureus RK Vajravelu, DM Guerrero, LA Jury, CJ Donskey Infection Control & Hospital Epidemiology 33 (1), 96-98, 2012 | 58 | 2012 |
| Delays related to prior authorization in inflammatory bowel disease BD Constant, EF de Zoeten, MG Stahl, RK Vajravelu, JD Lewis, ... Pediatrics 149 (3), e2021052501, 2022 | 39 | 2022 |
| Inflammatory bowel diseases are associated with an increased risk for chronic kidney disease, which decreases with age RK Vajravelu, L Copelovitch, MT Osterman, FI Scott, R Mamtani, JD Lewis, ... Clinical Gastroenterology and Hepatology 18 (10), 2262-2268, 2020 | 39 | 2020 |
| The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model FI Scott, RK Vajravelu, M Bewtra, R Mamtani, D Lee, DS Goldberg, ... Clinical Gastroenterology and Hepatology 13 (2), 302-309. e11, 2015 | 39 | 2015 |
| Early-onset esophageal adenocarcinoma presents with advanced-stage disease but has improved survival compared with older individuals JM Kolb, S Han, FI Scott, CC Murphy, P Hosokawa, S Wani, MB Cook, ... Gastroenterology 159 (6), 2238-2240. e4, 2020 | 32 | 2020 |
| Incidence, risk factors, and clinical effects of recurrent diverticular hemorrhage: a large cohort study RK Vajravelu, R Mamtani, FI Scott, A Waxman, JD Lewis Gastroenterology 155 (5), 1416-1427, 2018 | 32 | 2018 |
| Achalasia patients are at nutritional risk regardless of presenting weight category C Newberry, RK Vajravelu, O Pickett-Blakely, G Falk, YX Yang, KL Lynch Digestive Diseases and Sciences 63, 1243-1249, 2018 | 25 | 2018 |
| Long-term outcome of infliximab optimization for overcoming immunogenicity in patients with inflammatory bowel disease K Papamichael, RK Vajravelu, MT Osterman, AS Cheifetz Digestive diseases and sciences 63, 761-767, 2018 | 25 | 2018 |
| Characterization of prevalent, post-endoscopy, and incident esophageal cancer in the United States: a large retrospective cohort study RK Vajravelu, JM Kolb, SU Thanawala, FI Scott, S Han, AG Singal, ... Clinical Gastroenterology and Hepatology 20 (8), 1739-1747, 2022 | 23 | 2022 |
| Management of gastric GI stromal tumors: getting the GIST of it RK Rajravelu, GG Ginsberg Gastrointestinal Endoscopy 91 (4), 823-825, 2020 | 22 | 2020 |
| Magnitude and time-trend analysis of postendoscopy esophageal adenocarcinoma: a systematic review and meta-analysis T Sawas, AM Majzoub, J Haddad, T Tielleman, T Nayfeh, R Yadlapati, ... Clinical Gastroenterology and Hepatology 20 (2), e31-e50, 2022 | 19 | 2022 |
| Association between statin use at the time of intra-abdominal surgery and postoperative adhesion-related complications and small-bowel obstruction FI Scott, RK Vajravelu, R Mamtani, N Bianchina, N Mahmoud, JK Hou, ... JAMA Network Open 4 (2), e2036315-e2036315, 2021 | 19 | 2021 |
| Hospitalization outcomes for inflammatory bowel disease in teaching vs nonteaching hospitals RS Dalal, RK Vajravelu, JD Lewis, GR Lichtenstein Inflammatory bowel diseases 25 (12), 1974-1982, 2019 | 18 | 2019 |
| Environmental decontamination with ultraviolet radiation to prevent recurrent Clostridium difficile infection in 2 roommates in a long-term care facility B Sitzlar, RK Vajravelu, L Jury, CJ Donskey, RLP Jump Infection Control & Hospital Epidemiology 33 (5), 534-536, 2012 | 16 | 2012 |
| Long-term outcomes following multiply recurrent clostridioides difficile infection and fecal microbiota transplantation GK Dawwas, CM Brensinger, RK Vajravelu, Q Wu, CR Kelly, L Laine, ... Clinical Gastroenterology and Hepatology 20 (4), 806-816. e6, 2022 | 15 | 2022 |
| Indeterminate QuantiFERON-TB Gold increases likelihood of inflammatory bowel disease treatment delay and hospitalization RK Vajravelu, MT Osterman, FN Aberra, JA Roy, GR Lichtenstein, ... Inflammatory bowel diseases 24 (1), 217-226, 2018 | 15 | 2018 |
Frank I. Scott, MD MSCEDivision of Gastroenterology, University of Colorado Anschutz Medical Campus在 upenn.edu 的电子邮件经过验证
